This purely organic growth is the result of on-going capital investment (USD 3.1M to date) that we have been making to improve capacity, productivity and lead time.
Memphis, TN (PRWEB) July 23, 2014
In’Tech Medical SAS (http://www.intech-medical.com), a leading provider of high quality surgical instruments for the Orthopaedic market, announced today record revenues for the first semester of this year.
Group revenue for the first semester 2014 adds-up to USD 21.6M compared to USD 17.7M for the first semester of 2013, a revenue increase of 22.5%.
“This purely organic growth,” says Laurent Pruvost, In’Tech Medical President, “is the result of on-going capital investment (USD 3.1M to date) that we have been making to improve capacity, productivity and lead time.” He adds, “The surgical instruments that we manufacture are recognized for their performance, quality and elegance. Our investment program lays the foundation for a prosperous future focused on quality and customer service.”
In’Tech Medical is in high-growth mode both in the United States and in Europe and intends to stay this way, in an effort to bring the company even closer to its network of customers around the world, while intensifying local resources to meet demand in the ever growing Orthopaedic market.
Founded in France in 2000, In’Tech Medical is a privately held manufacturer of surgical instruments, specialized in Orthopedics. With a team of 280 dedicated employees, offices and production facilities in both Europe and the United States, the company is ideally positioned for sustainable growth and personalized customer care. In’Tech is proud to offer a comprehensive range of elegant “off-the-shelf” surgical instruments as well as cutting-edge systems, such as its proprietary “MIS Retractor.”